PGIM Jennison Health Sciences Fund held Vaxcyte stock in Q1 2025 and currently prefers AI stocks for higher returns.
2 reports, 0 independent
Updated Jul 8
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
PGIM Jennison Health Sciences Fund held Vaxcyte stock in Q1 2025 and currently prefers AI stocks for higher returns.
How it developed
Newest first. Tap a step to see who reported it.- Cantor Fitzgerald maintains an Overweight rating on Vaxcyte, with Gould explaining the firm's position amid ACIP meeting effects.Sub-event
- PGIM Fund held Vaxcyte stock and is prioritizing AI stocks for investment returns.
- Fund held CVS stock in Q1 2025 while maintaining preference for AI stocks.
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet